Global Spirometer Market

Global Spirometer Market Size, Share, Growth Analysis, By Product(Devices, Hand Held), By Technology(Volume Measurement, Flow Measurement), By End-use(Hospitals and Clinics, and Home Healthcare) - Industry Forecast 2024-2031


Report ID: SQMIG35A2503 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 92 | Figures: 76

Global Spirometer Market Dynamics

Global Spirometer Market Drivers

Rising Incidence of respiratory diseases

  • The escalating incidence of respiratory diseases represents a significant global health challenge, with several such diseases ranking among the top 30 causes of mortality. Notably, chronic obstructive pulmonary disease (COPD) stands as the third leading cause of death worldwide. The timely identification and diagnosis of respiratory ailments hold immense therapeutic value, significantly improving treatment outcomes. Within this context, spirometry emerges as a pivotal technology, aiding in the assessment of disease severity and mitigating the risk of misdiagnosis. Consequently, as the prevalence of respiratory diseases continues to surge, the spirometers market is poised for robust expansion. It's essential to acknowledge that advancing age diminishes the efficiency of vital bodily organs and physiological processes, accentuating the urgency for effective respiratory disease diagnosis and management.

Emerging economies

  • Growing economies like India, Brazil, China, and South Africa present substantial prospects for participants in the spirometry devices market. It's worth noting that among the top 20 most polluted cities globally, a striking 14 are located in India. Unfortunately, the adoption of spirometers for monitoring lung health remains quite limited in these nations.

Increasing Technological Advancement in Diagnostic Tools to Surge Demand

  • The demand for lung function tests is steadily increasing as they play a crucial role in assessing the fundamental functioning of the lungs. These tests, collectively known as Pulmonary Function Tests (PFTs), encompass parameters like lung volumes, capacities, flow rates, and gas exchange, providing valuable insights for diagnosing various lung disorders, particularly Chronic Obstructive Pulmonary Disease (COPD). Technological advancements are poised to significantly impact this market, with key industry players making substantial investments in research and development to create novel and advanced diagnostic and monitoring technologies, thereby facilitating the early detection of COPD.

Rising Prevalence of COPD to Propel Product Sales

  • The increasing prevalence of Chronic Obstructive Pulmonary Disease (COPD) is driving sales of diagnostic devices in response to a significant global health challenge. COPD stands as the third leading cause of death on a global scale and imposes substantial burdens on both patients and healthcare services. As per data from the National Heart, Lung, and Blood Institute, COPD is the primary cause of mortality in the United States, impacting approximately 16 million Americans. The primary risk factor associated with COPD is tobacco smoking, although other environmental factors such as air pollution and exposure to biomass fuels can also contribute to severe health complications. The escalating prevalence of this disorder represents a critical and widespread issue, spurring the demand for diagnostic devices throughout the forecast period.

Global Spirometer Market Restraints

Lack of Awareness and Availability

  • Despite the benefits of spirometry testing, there is a lack of awareness among patients and healthcare providers about its importance in the diagnosis and management of respiratory diseases. Additionally, the availability of spirometer devices may be limited in some regions, particularly in developing countries, which may limit the market's growth potential.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Spirometer Market size was valued at USD 1.10 billion in 2022 and is poised to grow from USD 1.21 billion in 2023 to USD 2.64 billion by 2031, growing at a CAGR of 10.20% during the forecast period (2024-2031).

The spirometer market is made up of respiratory device manufacturers as well as standalone spirometer producers. New technical advancements, such as the use of artificial intelligence, will generate growth prospects for new market entrants. For example, NuvoAir, a Swedish health care firm, created a digital platform that allows customers to perform at-home lung function tests. Companies are battling for market share, particularly in nations with advanced technology such as the United Kingdom, Germany, and the United States. Acquisitions and cooperation amongst market participants to strengthen their position have occurred. This is projected to increase market competition over the projection period. 'Hill-Rom Holdings, Inc.', 'Schiller AG', 'MGC Diagnostics Corporation', 'Vitalograph Ltd.', 'Vyaire Medical, Inc.', 'ndd Medizintechnik AG', 'Midmark Corporation', 'Medical International Research (MIR)', 'COSMED srl', 'Fukuda Sangyo Co., Ltd.', 'Thor Medical Systems', 'Nihon Kohden Corporation', 'Ganshorn Medizin Electronic GmbH', 'SDI Diagnostics', 'Jones Medical Instrument Company', 'NDD EasyOne Diagnostics', 'Morgan Scientific Inc.', 'M&B Electronic Instruments Inc.', 'Futuremed America Inc.', 'CareFusion Corporation'

Despite the benefits of spirometry testing, there is a lack of awareness among patients and healthcare providers about its importance in the diagnosis and management of respiratory diseases. Additionally, the availability of spirometer devices may be limited in some regions, particularly in developing countries, which may limit the market's growth potential.

Increasing adoption of portable and handheld spirometer devices: There is a growing trend toward the adoption of portable and handheld spirometer devices that are easy to use and provide accurate and reliable results. These devices are particularly useful in primary care settings and home healthcare settings, where they can be used to monitor patients with respiratory conditions and track changes in lung function over time.

North America dominated the market with a 41.6% share in 2022, owing mostly to the rising frequency of respiratory disorders. As the number of COPD and asthma cases rises, so does the usage of spirometers, which help in disease control and are routinely used by doctors in hospitals. Furthermore, the US has been highlighted as an early adopter of technology that aids in the decrease of COPD rates. Due to the one preceding, the market is expected to expand throughout the forecast period.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Spirometer Market

Product ID: SQMIG35A2503

$5,300
BUY NOW GET FREE SAMPLE